Lapidoth Capital Ltd (TLV:LAPD)
Israel · Delayed Price · Currency is ILS · Price in ILA 9,718.00
-86.00 (-0.88%)
At close: Jan 30, 2026
Lapidoth Capital Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 8,115 | 7,671 | 7,093 | 6,528 | 6,328 | 5,604 |
| 8,115 | 7,671 | 7,093 | 6,528 | 6,328 | 5,604 | |
Revenue Growth (YoY) | 13.64% | 8.14% | 8.67% | 3.16% | 12.90% | 301.31% |
Cost of Revenue | 7,521 | 7,079 | 6,492 | 5,855 | 5,771 | 5,184 |
Gross Profit | 593.89 | 592.16 | 601.79 | 672.99 | 557.13 | 420.19 |
Selling, General & Admin | 207.74 | 207.46 | 195.52 | 205.13 | 195.13 | 156.95 |
Other Operating Expenses | 3.6 | 2.21 | 1.85 | 0.38 | 3.23 | 2.47 |
Operating Expenses | 211.34 | 209.67 | 197.37 | 205.51 | 198.36 | 160.77 |
Operating Income | 382.55 | 382.49 | 404.43 | 467.48 | 358.77 | 259.41 |
Interest Expense | -98.83 | -87.9 | -71.36 | -70.67 | 14.99 | 12.83 |
Interest & Investment Income | 104.08 | 93.36 | 78.33 | 26.19 | 13.8 | 14.9 |
Earnings From Equity Investments | 57.43 | 66.39 | 20.92 | 32.96 | 61.1 | 10.19 |
Currency Exchange Gain (Loss) | 8.45 | 8.45 | -5.66 | 2.46 | -0.41 | -7.35 |
Other Non Operating Income (Expenses) | -13.53 | -13.53 | 19.9 | 31.43 | -71.97 | -116.38 |
EBT Excluding Unusual Items | 440.15 | 449.27 | 446.55 | 489.85 | 376.28 | 173.6 |
Gain (Loss) on Sale of Investments | 39.07 | 39.07 | 6.74 | -9.32 | 32.5 | -7.09 |
Asset Writedown | 81.64 | 68.22 | 37.96 | 83.97 | 84.4 | 20.66 |
Other Unusual Items | - | - | - | - | -7.44 | 120.6 |
Pretax Income | 560.85 | 556.55 | 491.25 | 564.5 | 485.74 | 307.77 |
Income Tax Expense | 99.13 | 101.08 | 104.58 | 116.6 | 103.59 | 37.3 |
Earnings From Continuing Operations | 461.72 | 455.48 | 386.67 | 447.89 | 382.15 | 270.47 |
Earnings From Discontinued Operations | -11.69 | -11.8 | -5.39 | -1.49 | - | - |
Net Income to Company | 450.03 | 443.68 | 381.28 | 446.4 | 382.15 | 270.47 |
Minority Interest in Earnings | -167.48 | -171.67 | -141.13 | -213.06 | -192.16 | -77.16 |
Net Income | 282.55 | 272.02 | 240.15 | 233.35 | 189.99 | 193.31 |
Preferred Dividends & Other Adjustments | 3.44 | 3.44 | 2.37 | -4.39 | 3.61 | 2.37 |
Net Income to Common | 279.11 | 268.57 | 237.78 | 237.74 | 186.38 | 190.94 |
Net Income Growth | 20.45% | 13.27% | 2.92% | 22.82% | -1.72% | 1227.66% |
Shares Outstanding (Basic) | 62 | 62 | 62 | 54 | 48 | 44 |
Shares Outstanding (Diluted) | 62 | 62 | 62 | 54 | 51 | 49 |
Shares Change (YoY) | 0.13% | -0.06% | 14.52% | 5.33% | 5.20% | 17.50% |
EPS (Basic) | 4.50 | 4.34 | 3.84 | 4.40 | 3.85 | 4.32 |
EPS (Diluted) | 4.50 | 4.34 | 3.84 | 4.40 | 3.63 | 3.91 |
EPS Growth | 20.04% | 13.02% | -12.70% | 21.17% | -7.16% | 1121.88% |
Free Cash Flow | 17.71 | -40.93 | 156.41 | 954.78 | 636.85 | 135.99 |
Free Cash Flow Per Share | 0.29 | -0.66 | 2.53 | 17.66 | 12.41 | 2.79 |
Dividend Per Share | 0.243 | 0.793 | 0.808 | 1.055 | 1.188 | - |
Dividend Growth | -72.17% | -1.83% | -23.42% | -11.18% | - | - |
Gross Margin | 7.32% | 7.72% | 8.48% | 10.31% | 8.80% | 7.50% |
Operating Margin | 4.71% | 4.99% | 5.70% | 7.16% | 5.67% | 4.63% |
Profit Margin | 3.44% | 3.50% | 3.35% | 3.64% | 2.94% | 3.41% |
Free Cash Flow Margin | 0.22% | -0.53% | 2.21% | 14.63% | 10.06% | 2.43% |
EBITDA | 446.86 | 434.02 | 455.14 | 557.74 | 430.56 | 339.42 |
EBITDA Margin | 5.51% | 5.66% | 6.42% | 8.54% | 6.80% | 6.06% |
D&A For EBITDA | 64.31 | 51.53 | 50.71 | 90.26 | 71.79 | 80.01 |
EBIT | 382.55 | 382.49 | 404.43 | 467.48 | 358.77 | 259.41 |
EBIT Margin | 4.71% | 4.99% | 5.70% | 7.16% | 5.67% | 4.63% |
Effective Tax Rate | 17.68% | 18.16% | 21.29% | 20.66% | 21.33% | 12.12% |
Revenue as Reported | 8,261 | 7,812 | 7,176 | 6,677 | 6,501 | 5,757 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.